West Pharmaceutical Services Inc (WST)

336.91 +4.38 (+1.32%) USD  |  NYSE  |  Jan 08, 16:00
334.11 -2.80 (-0.83%) Pre-Market: 08:16
More

West Pharmaceutical Services SG&A Expense (Quarterly): 83.50M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for WST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Merit Medical Systems Inc 99.64M
Repligen Corp 75.61M
Perspective Therapeutics Inc 6.975M
Xtant Medical Holdings Inc 19.38M
Catheter Precision Inc 2.882M